What is Olive Union?
Olive Union operates at the intersection of consumer electronics and medical technology, specializing in the development of advanced hearing aids and sound amplifiers. Their product portfolio, which includes the Olive Air, Olive Max, and Olive SmartEar Plus, is engineered to provide high-quality, accessible auditory solutions for individuals experiencing hearing loss. Unlike traditional hearing aid manufacturers, Olive Union differentiates itself by incorporating brain training programs directly into its devices, aiming to improve both auditory perception and cognitive function simultaneously. This holistic approach addresses the growing demand for affordable, user-friendly, and technologically sophisticated hearing health tools in an aging global population.
How much funding has Olive Union raised?
Olive Union has raised a total of $17M across 2 funding rounds:
Series A
$10M
Series B
$7M
Series A (2019): $10M with participation from LITALICO
Series B (2021): $7M led by Beyond Next Ventures Inc., Bonds Investment Group LLC, and Japan Finance
Key Investors in Olive Union
Beyond Next Ventures Inc.
A venture capital firm focused on supporting early-stage startups with high-impact technologies that address societal challenges.
Bonds Investment Group LLC
An investment firm specializing in strategic capital allocation to foster growth in emerging technology and consumer-facing enterprises.
Japan Finance
A public corporation providing financial services and support to businesses in Japan and internationally to promote economic development.
What's next for Olive Union?
With the recent infusion of capital, Olive Union is poised to accelerate its research and development initiatives, likely focusing on the next generation of AI-driven sound processing and miniaturization. The company is expected to leverage this financing to strengthen its market presence, potentially scaling its distribution channels and enhancing its digital health ecosystem. As the firm transitions into this new phase of growth, the integration of cognitive health features will remain a critical differentiator. Strategic priorities will likely include deepening its penetration in international markets and refining its direct-to-consumer model to ensure that high-fidelity hearing solutions remain both accessible and effective for a broader demographic of users.
See full Olive Union company page
